SOURCE: Eurand N.V.

Eurand N.V.

October 28, 2009 12:29 ET

Eurand to Participate in Upcoming Investor Conferences

PHILADELPHIA, PA--(Marketwire - October 28, 2009) - Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, is scheduled to participate in the following upcoming investor conferences:

Event:   Barclays Capital Healthcare Small Cap One on One Day
Date:    Tuesday, November 10, 2009
Time:    7:30 a.m. to 4:00 p.m. CT (Individual Meetings)
Place:   Graves 601 Hotel
         601 First Avenue North
         Minneapolis, Minn.

Event:   2009 Credit Suisse Healthcare Conference
Date:    Wednesday, November 11, 2009
Time:    10:00 a.m. MT (Presentation by Eurand Chief Commercial Officer
         John Fraher)
Place:   Arizona Biltmore
         2400 East Missouri Avenue
         Phoenix, Ariz.

An audio webcast of the Company's presentation at the Credit Suisse Conference will be available by accessing the investor relations section of and will be available via replay for 30 days following the date of the presentation.

About Eurand

Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies. Eurand has had six products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking orally disintegrating tablet (ODT) formulations, and drug conjugation. Eurand is a global company with facilities in the U.S. and Europe. For more information, visit

Contact Information